Kura Oncology (KURA) Amortizatization of Intangibles (2015 - 2026)

Kura Oncology (KURA) reported Amortizatization of Intangibles of $900000.0 for Q1 2026, down 66.19% year-over-year from $2.7 million in Q1 2025, and down 34.88% quarter-over-quarter from $1.4 million in Q4 2025.

Kura Oncology (KURA) Amortizatization of Intangibles (2015 - 2026) Analysis & Trends

Kura Oncology (KURA) has 12 years of Amortizatization of Intangibles data on file, last reported at $900000.0 in Q1 2026.

  • Amortizatization of Intangibles for Q1 2026 came in at $900000.0, down 66.19% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.7 million (down 46.33% YoY), and the FY2025 annual result was $8.5 million, down 35.41% from the prior year.
  • Amortizatization of Intangibles slipped to $900000.0 in Q1 2026 per KURA's latest filing, from $1.4 million in the prior quarter.
  • Over five years, Amortizatization of Intangibles peaked at $3.5 million in Q2 2024 and troughed at -$1.1 million in Q1 2022.
  • A 5-year average of $1.8 million and a median of $2.1 million in 2023 frame the typical range for Amortizatization of Intangibles.
  • The sharpest annual moves came in 2023 and 2026: Amortizatization of Intangibles jumped 881.08% in 2023, then slumped 66.19% in 2026.
  • A 5-year view of Amortizatization of Intangibles shows it stood at $654000.0 in 2022, then soared by 317.89% to $2.7 million in 2023, then grew by 5.56% to $2.9 million in 2024, then tumbled by 52.1% to $1.4 million in 2025, then plunged by 34.88% to $900000.0 in 2026.
  • Business Quant data shows KURA's Amortizatization of Intangibles at $900000.0 in Q1 2026, $1.4 million in Q4 2025, and $1.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 13,267.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Kura Oncology 883.44 Mn 883.44 Mn 18.00 Mn 900,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 900,000.00
Mar 31, 2026 900,000.00
Dec 31, 2025 1.38 Mn
Dec 31, 2025 1.38 Mn
Sep 30, 2025 1.92 Mn
Sep 30, 2025 1.92 Mn
Jun 30, 2025 2.52 Mn
Jun 30, 2025 2.52 Mn
Mar 31, 2025 2.66 Mn
Mar 31, 2025 2.66 Mn
Dec 31, 2024 2.89 Mn
Dec 31, 2024 2.89 Mn
Sep 30, 2024 3.44 Mn
Sep 30, 2024 3.44 Mn
Jun 30, 2024 3.55 Mn
Jun 30, 2024 3.55 Mn
Mar 31, 2024 3.27 Mn
Mar 31, 2024 3.27 Mn
Dec 31, 2023 2.73 Mn
Dec 31, 2023 2.73 Mn